Cohen Klingenstein LLC Gsk PLC Transaction History

Cohen Klingenstein LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 14, 2022	SELL	$38.88 - $45.31 $1.94 Million - $2.27 Million	-50,000 Reduced 19.12%	211,500 $9.33 Million
Q3 2021 Oct 15, 2021	SELL	$38.79 - $43.16 $280,451 - $312,046	-7,230 Reduced 2.69%	261,500 $9.99 Million
Q3 2019 Oct 17, 2019	BUY	$40.46 - $43.52 $1.05 Million - $1.13 Million	26,000 Added 10.71%	268,730 $11.5 Million
Q2 2019 Jul 15, 2019	SELL	$39.4 - $42.7 $1.02 Million - $1.11 Million	-26,000 Reduced 9.68%	242,730 $9.71 Million
Q1 2019 Apr 16, 2019	BUY	$38.57 - $42.69 $4.47 Million - $4.95 Million	116,000 Added 75.95%	268,730 $11.2 Million
Q3 2017 Oct 17, 2017	BUY	$39.44 - $41.55 $6.02 Million - $6.35 Million	152,730	152,730 $6.2 Million

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Cohen Klingenstein LLC, based on Form 13F filings with the SEC.

Stay updated on Cohen Klingenstein LLC with notifications on news.